𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Determination of mean residence time of drug in plasma and the influence of the initial drug elimination and distribution on the calculation of pharmacokinetic parameters

✍ Scribed by Leonid M. Berezhkovskiy


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
199 KB
Volume
98
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


The equation for the calculation of mean residence time of drug in plasma, t(p), is obtained. It is shown that the previously suggested calculation of t(p) considerably overestimates the true value in most cases. It is suggested that due to the possible initial (before establishing the uniform drug mixing in plasma) fast elimination of drug, the commonly calculated total body clearance (Cl = D/AUC) may substantially overestimate the clearance in the linear range of elimination of well-stirred drug. This would result in the high in vivo Cl values that are not supported by the in vitro studies of drug metabolism and stability in tissues. It is shown that the mean residence time of drug in the body, volumes of distribution, oral bioavailability and distribution clearance estimated with the account of initial drug distribution and elimination, may substantially deviate from the values obtained by the traditional calculations.


πŸ“œ SIMILAR VOLUMES


Mean residence time of drugs administere
✍ Haiyung Cheng πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 409 KB πŸ‘ 2 views

Based on disposition decomposition analysis (DDA), equations for the mean residence times (MRT) in the body are derived for a drug and its interconversion metabolite that undergo linear tissue distribution and linear or non-linear elimination from the central compartment after non-instantaneous admi

On the calculation of the concentration
✍ Leonid M. Berezhkovskiy πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 161 KB πŸ‘ 1 views

The measurement of the unbound drug fraction in plasma is routinely performed at drug concentrations much less than that of plasma proteins. Commonly, the protein has several binding sites of different affinities. The obtained value of the unbound drug fraction does not yield the affinity of each bi